Physician profile
Luning Chen
NPI 1306956529
$5,526.70
in general payments reported to CMS, 2019-2025
20 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,692 · 2020: $1,043 · 2021: $767 · 2022: $630 · 2023: $414 · 2024: $713 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,394.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,835.27 | 2019-2025 | Farxiga, Breztri |
| Amgen INC. | $1,318.11 | 2019-2024 | Evenity |
| Abbvie INC. | $521.54 | 2019-2024 | Viberzi, Linzess |
| Nestle Healthcare Nutrition INC. | $379.92 | 2020-2023 | |
| Lilly USA, LLC | $294.00 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $215.34 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $180.30 | 2024-2025 | |
| Vivus LLC | $120.00 | 2024 | Pancreaze |
| Gilead Sciences, INC. | $108.42 | 2021-2025 | |
| Balt USA, LLC | $105.59 | 2025 | Prestige Coil System |
| Dexcom, INC. | $99.20 | 2023 | Dexcom G7 Gss (161) |
| Radius Health, INC. | $90.35 | 2019 | |
| Scilex Pharmaceuticals INC. | $59.08 | 2019-2020 | |
| Pfizer INC. | $45.41 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.44 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $36.07 | 2020 | |
| Corium, LLC | $24.25 | 2022 | |
| Merck Sharp & Dohme LLC | $20.54 | 2020 | |
| Esperion Therapeutics, INC. | $19.89 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luning Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.